第一作者机构:[1]Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Beijing Key Lab Pediat Hematol Oncol, Beijing, Peoples R China[2]Capital Med Univ, Beijing Key Lab Pediat Hematol Oncol, Beijing, Peoples R China[3]Capital Med Univ, Natl Key Discipline Pediat, Beijing, Peoples R China[4]Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China[5]Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Hematol Oncol Ctr, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Ang Wei,Ma Honghao,Wang Tianyou,et al.CLINICAL CHARACTERISTICS AND TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILDREN[J].PEDIATRIC BLOOD & CANCER.2020,67:S36-S37.
APA:
Ang Wei,Ma Honghao,Wang Tianyou,Zhang Li,Lian Hongyun...&Zhang Rui.(2020).CLINICAL CHARACTERISTICS AND TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILDREN.PEDIATRIC BLOOD & CANCER,67,
MLA:
Ang Wei,et al."CLINICAL CHARACTERISTICS AND TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILDREN".PEDIATRIC BLOOD & CANCER 67.(2020):S36-S37